The Pain and Anxiety in Children With Intramuscular Injection
NCT ID: NCT05444634
Last Updated: 2023-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2022-05-01
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IM İnjection-PAIN-Cold Spray and Stress Ball
NCT07233694
The Effect of Shotblocker, Finger Puppet And Balloon Method During Intramuscular Injection
NCT05725551
Effect of Acupressure Therapy on Pain, Fear, and Post-Injection Satisfaction in Patients Undergoing IM Injection
NCT07063160
Nonpharmacological Methods for Children
NCT05070325
Stress Ball During Lumbar Puncture the Effect of the Application on Anxiety Level
NCT06146543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
"Descriptive Information Form", "Wong Baker Faces Pain Rating Scale", "Venham Anxiety Rating Picture Scale" will be used in data collection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
distraction card
Immediately before the procedure, the child will be asked questions about the distraction cards. Questions about the cards will continue to be asked immediately after the intramuscular injection is finished.
Distraction Card
Suitable for children over 3 years old. 1 set of 32 pieces of thick cardboard cards It has been prepared by child development experts in line with pedagogical principles.
Size: 13cm x 8cm, Each card illustrates the skills and actions the children do.
Stress Ball
The child will be informed about the stress ball and asked to play continuously
Stress Ball
Brain Shaped Stress Ball, White rope in the form of mesh around the inner silicone Size: Approx 2.4 inches (6 cm), Color: Colorful, When squeezed, the silicone structure comes out in the mesh spaces and turns into a bunch of grapes.
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Distraction Card
Suitable for children over 3 years old. 1 set of 32 pieces of thick cardboard cards It has been prepared by child development experts in line with pedagogical principles.
Size: 13cm x 8cm, Each card illustrates the skills and actions the children do.
Stress Ball
Brain Shaped Stress Ball, White rope in the form of mesh around the inner silicone Size: Approx 2.4 inches (6 cm), Color: Colorful, When squeezed, the silicone structure comes out in the mesh spaces and turns into a bunch of grapes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intramuscular administration of ondansetron hcl active ingredient drug
* Mentally and physically handicapped
* Does not have a disease that causes chronic pain
* Open to communication
* Fluent in Turkish
Exclusion Criteria
* Children who do not give verbal consent appropriate to the child's developmental level
3 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MSc Merve Eroğlu
UNKNOWN
Ataturk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Türkan Kadiroğlu
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ataturk University
Erzurum, Erzuum, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B.30.2.ATA.O.01.00/265
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.